Progressive strength training to prevent LYmphoedema in the first year after breast CAncer: the LYCA feasibility study

Publikation: Bidrag til tidsskriftKonferenceartikelForskningfagfællebedømt

Standard

Progressive strength training to prevent LYmphoedema in the first year after breast CAncer : the LYCA feasibility study. / Ammitzbøll, Gunn; Lanng, Charlotte; Kroman, Niels; Zerahn, Bo; Hyldegaard, Ole; Kaae Andersen, Klaus; Johansen, Christoffer; Dalton, Susanne Oksbjerg.

I: Acta Oncologica, Bind 56, Nr. 2, 2017, s. 360-366.

Publikation: Bidrag til tidsskriftKonferenceartikelForskningfagfællebedømt

Harvard

Ammitzbøll, G, Lanng, C, Kroman, N, Zerahn, B, Hyldegaard, O, Kaae Andersen, K, Johansen, C & Dalton, SO 2017, 'Progressive strength training to prevent LYmphoedema in the first year after breast CAncer: the LYCA feasibility study', Acta Oncologica, bind 56, nr. 2, s. 360-366. https://doi.org/10.1080/0284186X.2016.1268266

APA

Ammitzbøll, G., Lanng, C., Kroman, N., Zerahn, B., Hyldegaard, O., Kaae Andersen, K., Johansen, C., & Dalton, S. O. (2017). Progressive strength training to prevent LYmphoedema in the first year after breast CAncer: the LYCA feasibility study. Acta Oncologica, 56(2), 360-366. https://doi.org/10.1080/0284186X.2016.1268266

Vancouver

Ammitzbøll G, Lanng C, Kroman N, Zerahn B, Hyldegaard O, Kaae Andersen K o.a. Progressive strength training to prevent LYmphoedema in the first year after breast CAncer: the LYCA feasibility study. Acta Oncologica. 2017;56(2):360-366. https://doi.org/10.1080/0284186X.2016.1268266

Author

Ammitzbøll, Gunn ; Lanng, Charlotte ; Kroman, Niels ; Zerahn, Bo ; Hyldegaard, Ole ; Kaae Andersen, Klaus ; Johansen, Christoffer ; Dalton, Susanne Oksbjerg. / Progressive strength training to prevent LYmphoedema in the first year after breast CAncer : the LYCA feasibility study. I: Acta Oncologica. 2017 ; Bind 56, Nr. 2. s. 360-366.

Bibtex

@inproceedings{b722e85b69194eedb666aad86ff4bacb,
title = "Progressive strength training to prevent LYmphoedema in the first year after breast CAncer: the LYCA feasibility study",
abstract = "BACKGROUND: Lymphoedema is a common late effect after breast cancer (BC) that has no effective cure once chronic. Accumulating evidence supports progressive strength training (PRT) as a safe exercise modality in relation to the onset and exacerbation of lymphoedema. In the 'preventive intervention against LYmphoedema after breast CAncer' (LYCA) feasibility study we examined the feasibility of a program of PRT in the first year after BC to inform a planned randomised controlled trial (RCT).MATERIAL AND METHODS: LYCA was a one-group prospective pilot trial inviting women operated with axillary lymph node dissection for unilateral primary BC. Participants exercised three times a week for 50 weeks (20 weeks supervised followed by 30 weeks home-based exercise). The program ensured slow individualised progression during the exercise program. The primary outcome was feasibility measured by eligibility and recruitment rates, as well as questionnaire-assessed satisfaction and adherence to exercise. Furthermore, we assessed arm interlimb volume difference by water displacement, muscle strength by dynamic and isometric muscle testing and range of movement in the shoulder by goniometry.RESULTS: In August 2015, eight of 11 eligible patients accepted participation. Two of them dropped out early due to other health issues. The remaining six participants had high exercise adherence through the supervised period, but only three maintained this through the home exercise period. Program satisfaction was high and no serious adverse events from testing or exercising were reported. One participant presented with lymphoedema at 50-week follow-up. Muscle strength markedly increased with supervised exercise, but was not fully maintained through the home exercise period. Range of shoulder movement was not negatively affected by the program.CONCLUSION: Recruitment, testing, and exercise in LYCA was safe and feasible. At the 50-week follow-up, there was one case of lymphoedema. The LYCA program will be further tested in a full-scale RCT.",
keywords = "Aged, Body Composition, Breast Cancer Lymphedema/prevention & control, Breast Neoplasms/physiopathology, Feasibility Studies, Female, Humans, Middle Aged, Muscle Strength, Pilot Projects, Prospective Studies, Resistance Training",
author = "Gunn Ammitzb{\o}ll and Charlotte Lanng and Niels Kroman and Bo Zerahn and Ole Hyldegaard and {Kaae Andersen}, Klaus and Christoffer Johansen and Dalton, {Susanne Oksbjerg}",
year = "2017",
doi = "10.1080/0284186X.2016.1268266",
language = "English",
volume = "56",
pages = "360--366",
journal = "Acta Oncologica",
issn = "1100-1704",
publisher = "Taylor & Francis",
number = "2",

}

RIS

TY - GEN

T1 - Progressive strength training to prevent LYmphoedema in the first year after breast CAncer

T2 - the LYCA feasibility study

AU - Ammitzbøll, Gunn

AU - Lanng, Charlotte

AU - Kroman, Niels

AU - Zerahn, Bo

AU - Hyldegaard, Ole

AU - Kaae Andersen, Klaus

AU - Johansen, Christoffer

AU - Dalton, Susanne Oksbjerg

PY - 2017

Y1 - 2017

N2 - BACKGROUND: Lymphoedema is a common late effect after breast cancer (BC) that has no effective cure once chronic. Accumulating evidence supports progressive strength training (PRT) as a safe exercise modality in relation to the onset and exacerbation of lymphoedema. In the 'preventive intervention against LYmphoedema after breast CAncer' (LYCA) feasibility study we examined the feasibility of a program of PRT in the first year after BC to inform a planned randomised controlled trial (RCT).MATERIAL AND METHODS: LYCA was a one-group prospective pilot trial inviting women operated with axillary lymph node dissection for unilateral primary BC. Participants exercised three times a week for 50 weeks (20 weeks supervised followed by 30 weeks home-based exercise). The program ensured slow individualised progression during the exercise program. The primary outcome was feasibility measured by eligibility and recruitment rates, as well as questionnaire-assessed satisfaction and adherence to exercise. Furthermore, we assessed arm interlimb volume difference by water displacement, muscle strength by dynamic and isometric muscle testing and range of movement in the shoulder by goniometry.RESULTS: In August 2015, eight of 11 eligible patients accepted participation. Two of them dropped out early due to other health issues. The remaining six participants had high exercise adherence through the supervised period, but only three maintained this through the home exercise period. Program satisfaction was high and no serious adverse events from testing or exercising were reported. One participant presented with lymphoedema at 50-week follow-up. Muscle strength markedly increased with supervised exercise, but was not fully maintained through the home exercise period. Range of shoulder movement was not negatively affected by the program.CONCLUSION: Recruitment, testing, and exercise in LYCA was safe and feasible. At the 50-week follow-up, there was one case of lymphoedema. The LYCA program will be further tested in a full-scale RCT.

AB - BACKGROUND: Lymphoedema is a common late effect after breast cancer (BC) that has no effective cure once chronic. Accumulating evidence supports progressive strength training (PRT) as a safe exercise modality in relation to the onset and exacerbation of lymphoedema. In the 'preventive intervention against LYmphoedema after breast CAncer' (LYCA) feasibility study we examined the feasibility of a program of PRT in the first year after BC to inform a planned randomised controlled trial (RCT).MATERIAL AND METHODS: LYCA was a one-group prospective pilot trial inviting women operated with axillary lymph node dissection for unilateral primary BC. Participants exercised three times a week for 50 weeks (20 weeks supervised followed by 30 weeks home-based exercise). The program ensured slow individualised progression during the exercise program. The primary outcome was feasibility measured by eligibility and recruitment rates, as well as questionnaire-assessed satisfaction and adherence to exercise. Furthermore, we assessed arm interlimb volume difference by water displacement, muscle strength by dynamic and isometric muscle testing and range of movement in the shoulder by goniometry.RESULTS: In August 2015, eight of 11 eligible patients accepted participation. Two of them dropped out early due to other health issues. The remaining six participants had high exercise adherence through the supervised period, but only three maintained this through the home exercise period. Program satisfaction was high and no serious adverse events from testing or exercising were reported. One participant presented with lymphoedema at 50-week follow-up. Muscle strength markedly increased with supervised exercise, but was not fully maintained through the home exercise period. Range of shoulder movement was not negatively affected by the program.CONCLUSION: Recruitment, testing, and exercise in LYCA was safe and feasible. At the 50-week follow-up, there was one case of lymphoedema. The LYCA program will be further tested in a full-scale RCT.

KW - Aged

KW - Body Composition

KW - Breast Cancer Lymphedema/prevention & control

KW - Breast Neoplasms/physiopathology

KW - Feasibility Studies

KW - Female

KW - Humans

KW - Middle Aged

KW - Muscle Strength

KW - Pilot Projects

KW - Prospective Studies

KW - Resistance Training

U2 - 10.1080/0284186X.2016.1268266

DO - 10.1080/0284186X.2016.1268266

M3 - Conference article

C2 - 28084150

VL - 56

SP - 360

EP - 366

JO - Acta Oncologica

JF - Acta Oncologica

SN - 1100-1704

IS - 2

ER -

ID: 193902610